COURTNEY MILLER: Open Payments
NPI 1275006819 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 98 payments from 20 companies in 2025. Trend: 2023 $378 · 2024 $2,270 · 2025 $1,502
Food & beverage: $1,369Education: $133
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 30 | $236 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| GENZYME CORPORATION | 10 | $150 |
| GlaxoSmithKline, LLC. | 18 | $148 |
| Amgen Inc. | 7 | $140 |
| ANI Pharmaceuticals, Inc. | 5 | $103 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $96 |
| Regeneron Healthcare Solutions, Inc. | 2 | $78 |
| Inspire Medical Systems, Inc. | 1 | $42 |
Products named: DUPIXENT, Ohtuvayre, TEZSPIRE, PURIFIED CORTROPHIN GEL, NUCALA, GLASSIA, AIRSUPRA, FASENRA.
Industry payments across IN — which companies pay providers there.
